• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LUO Kaiming, ZHAO Hu, GAO Xiangdong. Preparation of a monoclonal antibody against hyaluronic acid and its application in immunoassay[J]. Journal of China Pharmaceutical University, 2015, 46(6): 740-744. DOI: 10.11665/j.issn.1000-5048.20150618
Citation: LUO Kaiming, ZHAO Hu, GAO Xiangdong. Preparation of a monoclonal antibody against hyaluronic acid and its application in immunoassay[J]. Journal of China Pharmaceutical University, 2015, 46(6): 740-744. DOI: 10.11665/j.issn.1000-5048.20150618

Preparation of a monoclonal antibody against hyaluronic acid and its application in immunoassay

More Information
  • This study was to develop a quantitative immunoassay for hyaluronic acid(HA). We firstly prepared a monoclonal antibody(MAb)against it. HA, activated by 1-cyano-4-dimethyl-aminopyridinium tetrafluoroborate(CDAP), was coupled to bovine serum albumin(BSA). BALB/c mice were immunized with purified complete antigen BSA-HA and the monoclonal antibody was prepared by hybridoma technique. To characterize the specificity of the antibody, inhibition enzyme-linked immunosorbent assay(ELISA)was conducted and the cross reactivity along with affinity constant was determined. The results showed that the substitution degree of BSA-HA(mBSA/wHA)was about 9. Also, a hybridoma cell line named 8B6 was obtained by hybridoma technology. The indirect ELISA titer of the ascetic fluid was 1 ∶256 000; the isotype of MAb 8B6 was IgG1 and the affinity constant was Ka=6. 71×109 mol-1. To establish the indirect competitive ELISA method, polystyrene microwell plates were coated with 10. 0 ng/mL HA and blocked with 1. 0% BSA. The linear range of indirect competitive ELISA was between 10. 0 ng/mL to 10. 0 μg/mL which confirmed that the method was specific and sensitive.
  • [1]
    Lapcík L Jr,Lapcík L,De Smedt S,et al.Hyaluronan:preparation,structure,properties,and applications[J].Chem Rev,1998,98(8):2663-2684.
    [2]
    Choi KY, Chung H, Min KH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting[J].Biomaterials,2010,31(1):106-114.
    [3]
    Mironov V,Kasyanov V,Shu XZ,et al.Fabrication of tubular tissue constructs by centrifugal casting of cells suspended in an in situ crosslinkable hyaluronan-gelatin hydrogel[J].Biomaterials,2005,26(36):7628-7635.
    [4]
    Lee H, Lee K, Park TG. Hyaluronic acid-paclitaxel conjugate micelles:synthesis,characterization,and antitumor activity[J].Bioconjug Chem,2008,19(6):1319-1325.
    [5]
    Peng C, Ge H, He S, et al. Molecular cloning expression and identification of recombinant hyaluronan synthase from Pasteurella multocida[J].J China Pharm Univ(中国药科大学学报),2009,40(6):549-552.
    [6]
    Vasi AM,Popa MI,Butnaru M,et al.Chemical functionalization of hyaluronic acid for drug delivery applications[J].Mater Sci Eng C Mater Biol Appl,2014,38:177-185.
    [7]
    Kamat M,El-Boubbou K,Zhu DC,et al.Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages[J].Bioconjug Chem,2010,21(11):2128-2135.
    [8]
    Widner B,Behr R,Von Dollen S,et al.Hyaluronic acid production in Bacillus subtilis[J].Appl Environ Microbiol,2005,71(7):3747-3752.
    [9]
    Chien LJ,Lee CK.Enhanced hyaluronic acid production in Bacillus subtilis by coexpressing bacterial hemoglobin[J].Biotechnol Prog,2007,23(5):1017-1022.
    [10]
    Jia Y,Zhu J,Chen X,et al.Metabolic engineering of Bacillus subtilis for the efficient biosynthesis of uniform hyaluronic acid with controlled molecular weights[J].Bioresour Technol,2013,132:427-431.
    [11]
    Yu H,Stephanopoulos G.Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid[J].Metab Eng,2008,10(1):24-32.
    [12]
    Mao Z,Shin HD,Chen R.A recombinant E.coli bioprocess for hyaluronan synthesis[J].Appl Microbiol Biotechnol,2009,84(1):63-69.
    [13]
    Prasad SB,Jayaraman G,Ramachandran KB.Hyaluronic acid production is enhanced by the additional co-expression of UDP-glucose pyrophosphorylase in Lactococcus lactis[J].Appl Microbiol Biotechnol,2010,86(1):273-283.
    [14]
    Prasad SB,Ramachandran KB,Jayaraman G.Transcription analysis of hyaluronan biosynthesis genes in Streptococcus zooepidemicus and metabolically engineered Lactococcus lactis[J].Appl Microbiol Biotechnol,2012,94(6):1593-1607.
    [15]
    Oueslati N,Leblanc P,Harscoat-Schiavo C,et al.CTAB turbidimetric method for assaying hyaluronic acid in complex environments and under cross-linked form[J].Carbohydr Polym,2014,112(21):102-108.
    [16]
    Jeong E,Shim WY,Kim JH.Metabolic engineering of Pichia pastoris for production of hyaluronic acid with high molecular weight[J].J Biotechnol,2014,185:28-36.
    [17]
    Luo HQ,Li NB,Liu SP.Resonance Rayleigh scattering study of interaction of hyaluronic acid with ethyl violet dye and its analytical application[J].Biosens Bioelectron,2006,21(7):1186-1194.
    [18]
    Lei X,Zhao J,Wang X,et al.Development of a hybridoma cell line secreting monoclonal antibody against S protein of a Chinese variant of PEDV[J].Monoclon Antib Immunodiagn Immunother,2015,34(1):12-16.
    [19]
    Namkoong H,Funatsu Y,Oishi K,et al.Comparison of the immunogenicity and safety of polysaccharide and protein-conjugated pneumococcal vaccines among the elderly aged 80 years or older in Japan:an open-labeled randomized study[J].Vaccine,2015,33(2):327-332.
    [20]
    Chu C,Schneerson R,Robbins JB,et al.Further studies on the immunogenicity of haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates[J].Infect Immun,1983,40(1):245-256.
    [21]
    Lees A,Nelson BL,Mond JJ.Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents[J].Vaccine,1996,14(3):190-198.
  • Related Articles

    [1]CHEN Feihong, ZHAO Deming, GOU Shaohua. Research progress on the antitumor effects of platinum-based chemo-immunotherapies[J]. Journal of China Pharmaceutical University, 2024, 55(1): 26-35. DOI: 10.11665/j.issn.1000-5048.2023120201
    [2]XU Yungen. Advances in drug development based on immunoregulation[J]. Journal of China Pharmaceutical University, 2024, 55(1): 1-4. DOI: 10.11665/j.issn.1000-5048.2024022601
    [3]YU Dongmei, GUO Wei, LEI Wen, GE Yaoyao, CHEN Yucong, GAO Xiangdong, YAO Wenbing. Advances of lncRNA in immune cells and autoimmune diseases[J]. Journal of China Pharmaceutical University, 2017, 48(3): 371-376. DOI: 10.11665/j.issn.1000-5048.20170319
    [4]LIANG Xiao-qing, SHI Chen-yang, WANG Ke, HE Xin, LIU Si-guo, HUANG Xiao-feng, LIU Yu. Anti-angiogenesis and anti-tumor activity of the fully human anti-VEGF165 monoclonal antibody obtained from the five-feature transgenic mice[J]. Journal of China Pharmaceutical University, 2012, 43(6): 560-566.
    [5]Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10.
    [8]Effects of Mixed Nucleotide on Acute Hepatic Injury and Immunoregulation in Mice[J]. Journal of China Pharmaceutical University, 2001, (6): 44-47.
    [9]Immunomodulating Activity of Yang Zheng He Ji[J]. Journal of China Pharmaceutical University, 1995, (1): 37-40.
    [10]The Immunoregulative Effect of the Synthetic Artifact of Royel Jelly Acid[J]. Journal of China Pharmaceutical University, 1991, (2): 117-118.
  • Cited by

    Periodical cited type(3)

    1. 曾雪亮,钟文敏,李蓓. 异甘草酸镁联合疗法治疗慢性乙型肝炎的效果及安全性的meta分析. 中国当代医药. 2021(30): 13-17 .
    2. 高华,何海妮,刘莉娜. 异甘草酸镁注射液对耐多药结核鼠T淋巴细胞亚群及血清抗体的影响. 临床和实验医学杂志. 2020(22): 2382-2385 .
    3. 柏杰. 双环醇联合异甘草酸镁治疗失代偿期肝硬化疗效观察. 智慧健康. 2020(31): 115-116 .

    Other cited types(1)

Catalog

    Article views (1428) PDF downloads (2184) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return